Baher I. Salman*a,
Adel Ehab Ibrahimbc,
Sami El Deebbd and
Roshdy E. Sarayac
aPharmaceutical Analytical Chemistry Department, Faculty of Pharmacy, Al-Azhar University, Assiut Branch, Assiut, Egypt. E-mail: bahersalman@azhar.edu.eg; bahersalman2013@yahoo.com; Tel: +201099031345
bNatural and Medical Sciences Research Center, University of Nizwa, Birket Almawz, P. O. box 33, Oman
cDepartment of Pharmaceutical Analytical Chemistry, Faculty of Pharmacy, Port Said University, Port Said 42511, Egypt
dInstitute of Medicinal and Pharmaceutical Chemistry, Technische Universitaet Braunschweig, 38106 12 Braunschweig, Germany
First published on 8th November 2024
Retraction of ‘Fabrication of novel quantum dots for the estimation of COVID-19 antiviral drug using green chemistry: application to real human plasma’ by Baher I. Salman et al., RSC Adv., 2022, 12, 16624–16631, https://doi.org/10.1039/D2RA02241A.
The left side TEM image of Fig. 1a shows inconsistencies in the background that the authors have not been able to satisfactorily explain.
The PXRD spectrum in Fig. 1d contains repeating patterns and there are anomalies in the X-axis.
The EDX spectrum in Fig. 2a contains repeating patterns.
An independent expert was consulted who was not satisfied with the explanation provided by the authors.
Given the significance of the concern about the validity of the data, the findings presented in this paper are no longer reliable. The authors have cooperated throughout the investigation and have endeavoured to be transparent regarding the errors in the data.
Signed: Baher I. Salman, Adel Ehab Ibrahim, Sami El Deeb, Roshdy E. Saraya
Date: 9th October 2024
Retraction endorsed by Laura Fisher, Executive Editor, RSC Advances
This journal is © The Royal Society of Chemistry 2024 |